Arkolith/Insider Trading/AMAM/Form 4

O'Connor Daniel J.

President and CEO, DirectorAmbrx Biopharma, Inc. (AMAM) · full profile →Form 4 · filed Oct 31, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$491K
Net Open-Market Flow
-$491K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2023Sell(S)50K$9.82$491K343K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-056943) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML